Top Markets
Coin of the day
Bio Preventive Medicine Corp. Bio Preventive Medicine Corp.

Bio Preventive Medicine Corp.

6810
Rank in Stocks #27174
Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical... Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.
Share Price
$0.70116857
Market Cap
$34.67M
Change (1 day)
-1.78%
Change (1 year)
-18.30%
Country
TW
Trade Bio Preventive Medicine Corp. (6810)

Category

Operating Margin for Bio Preventive Medicine Corp. (6810)
Operating Margin as of 2026 TTM: 0.00%
According to Bio Preventive Medicine Corp. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Bio Preventive Medicine Corp. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
-149.01% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.